
Christopher C. Caillouet
Examiner (ID: 8951, Phone: (571)270-3968 , Office: P/1745 )
| Most Active Art Unit | 1745 |
| Art Unit(s) | 1791, 1745 |
| Total Applications | 862 |
| Issued Applications | 546 |
| Pending Applications | 67 |
| Abandoned Applications | 259 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1111377
[patent_doc_number] => 06806277
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-10-19
[patent_title] => 'Quinolylpropylpiperidine derivatives, preparation process and intermediates, and compositions including them'
[patent_app_type] => B2
[patent_app_number] => 10/622655
[patent_app_country] => US
[patent_app_date] => 2003-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11203
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 375
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/806/06806277.pdf
[firstpage_image] =>[orig_patent_app_number] => 10622655
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/622655 | Quinolylpropylpiperidine derivatives, preparation process and intermediates, and compositions including them | Jul 17, 2003 | Issued |
Array
(
[id] => 7386614
[patent_doc_number] => 20040082591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-29
[patent_title] => 'Therapeutic heterocyclic compounds'
[patent_app_type] => new
[patent_app_number] => 10/466540
[patent_app_country] => US
[patent_app_date] => 2003-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37007
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20040082591.pdf
[firstpage_image] =>[orig_patent_app_number] => 10466540
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/466540 | Therapeutic heterocyclic compounds | Jul 15, 2003 | Abandoned |
Array
(
[id] => 5743655
[patent_doc_number] => 20060089380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => '8-Hydroxy quinoline derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/521902
[patent_app_country] => US
[patent_app_date] => 2003-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 35610
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20060089380.pdf
[firstpage_image] =>[orig_patent_app_number] => 10521902
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/521902 | 8-hydroxy quinoline derivatives | Jul 15, 2003 | Issued |
Array
(
[id] => 528345
[patent_doc_number] => 07183411
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-27
[patent_title] => 'Naphthol, quinoline and isoquinoline-derived urea modulators of vanilloid VR1 receptor'
[patent_app_type] => utility
[patent_app_number] => 10/616579
[patent_app_country] => US
[patent_app_date] => 2003-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55094
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/183/07183411.pdf
[firstpage_image] =>[orig_patent_app_number] => 10616579
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/616579 | Naphthol, quinoline and isoquinoline-derived urea modulators of vanilloid VR1 receptor | Jul 9, 2003 | Issued |
Array
(
[id] => 5743657
[patent_doc_number] => 20060089382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Substituted 3-cyanoquinolines as mek inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/520468
[patent_app_country] => US
[patent_app_date] => 2003-07-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39060
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20060089382.pdf
[firstpage_image] =>[orig_patent_app_number] => 10520468
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/520468 | Substituted 3-cyanoquinolines as MEK inhibitors | Jul 3, 2003 | Issued |
Array
(
[id] => 7474850
[patent_doc_number] => 20040097541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Pyrazoloisoquinoline derivatives for inhibiting NFkappaB-inducing kinase'
[patent_app_type] => new
[patent_app_number] => 10/613482
[patent_app_country] => US
[patent_app_date] => 2003-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10674
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20040097541.pdf
[firstpage_image] =>[orig_patent_app_number] => 10613482
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/613482 | Pyrazoloisoquinoline derivatives for inhibiting NFκB-inducing kinase | Jul 2, 2003 | Issued |
Array
(
[id] => 7474884
[patent_doc_number] => 20040097545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Quinolinone derivatives'
[patent_app_type] => new
[patent_app_number] => 10/613411
[patent_app_country] => US
[patent_app_date] => 2003-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50084
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20040097545.pdf
[firstpage_image] =>[orig_patent_app_number] => 10613411
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/613411 | Quinolinone derivatives | Jul 2, 2003 | Issued |
Array
(
[id] => 938464
[patent_doc_number] => 06972293
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-12-06
[patent_title] => 'Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors'
[patent_app_type] => utility
[patent_app_number] => 10/609941
[patent_app_country] => US
[patent_app_date] => 2003-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24072
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/972/06972293.pdf
[firstpage_image] =>[orig_patent_app_number] => 10609941
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/609941 | Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors | Jun 29, 2003 | Issued |
Array
(
[id] => 1005485
[patent_doc_number] => 06906082
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-06-14
[patent_title] => '4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines'
[patent_app_type] => utility
[patent_app_number] => 10/607640
[patent_app_country] => US
[patent_app_date] => 2003-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36973
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/906/06906082.pdf
[firstpage_image] =>[orig_patent_app_number] => 10607640
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/607640 | 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines | Jun 26, 2003 | Issued |
Array
(
[id] => 7288223
[patent_doc_number] => 20040147518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them'
[patent_app_type] => new
[patent_app_number] => 10/607220
[patent_app_country] => US
[patent_app_date] => 2003-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 132998
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20040147518.pdf
[firstpage_image] =>[orig_patent_app_number] => 10607220
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/607220 | Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them | Jun 26, 2003 | Issued |
Array
(
[id] => 7453779
[patent_doc_number] => 20040067968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-08
[patent_title] => 'Farnesyl transferase inhibiting 4-heterocyclyl quinoline and quinazoline'
[patent_app_type] => new
[patent_app_number] => 10/250381
[patent_app_country] => US
[patent_app_date] => 2003-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18403
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0067/20040067968.pdf
[firstpage_image] =>[orig_patent_app_number] => 10250381
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/250381 | Farnesyl transferase inhibiting 4-heterocyclyl quinoline and quinazoline | Jun 25, 2003 | Abandoned |
Array
(
[id] => 5748436
[patent_doc_number] => 20060111368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Phosphodiesterase inhibitor'
[patent_app_type] => utility
[patent_app_number] => 10/519197
[patent_app_country] => US
[patent_app_date] => 2003-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17107
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20060111368.pdf
[firstpage_image] =>[orig_patent_app_number] => 10519197
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/519197 | Phosphodiesterase inhibitor | Jun 25, 2003 | Abandoned |
Array
(
[id] => 7363734
[patent_doc_number] => 20040014979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'C7 ester substituted taxanes'
[patent_app_type] => new
[patent_app_number] => 10/606027
[patent_app_country] => US
[patent_app_date] => 2003-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17268
[patent_no_of_claims] => 169
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20040014979.pdf
[firstpage_image] =>[orig_patent_app_number] => 10606027
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/606027 | C7 ester substituted taxanes | Jun 24, 2003 | Issued |
Array
(
[id] => 6967341
[patent_doc_number] => 20050234238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => '8-(Biaryl)quinoline pde4 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/517416
[patent_app_country] => US
[patent_app_date] => 2003-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37402
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20050234238.pdf
[firstpage_image] =>[orig_patent_app_number] => 10517416
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/517416 | 8-(biaryl)quinoline PDE4 inhibitors | Jun 22, 2003 | Issued |
Array
(
[id] => 1170847
[patent_doc_number] => 06753430
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-06-22
[patent_title] => 'Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof'
[patent_app_type] => B2
[patent_app_number] => 10/600631
[patent_app_country] => US
[patent_app_date] => 2003-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13086
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/753/06753430.pdf
[firstpage_image] =>[orig_patent_app_number] => 10600631
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/600631 | Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof | Jun 19, 2003 | Issued |
Array
(
[id] => 7281611
[patent_doc_number] => 20040063988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'Preparation of at least one partial oxidation and/or ammoxidation product of propylene'
[patent_app_type] => new
[patent_app_number] => 10/465656
[patent_app_country] => US
[patent_app_date] => 2003-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29983
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 37
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20040063988.pdf
[firstpage_image] =>[orig_patent_app_number] => 10465656
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/465656 | Preparation of at least one partial oxidation and/or ammoxidation product of propylene | Jun 19, 2003 | Issued |
Array
(
[id] => 5829197
[patent_doc_number] => 20060063801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Novel 3-(4-oxo-4h-chromen-2-yl)-(1H)-quinolin-4-one derivatives, method for preparing same and pharmaceutical compositions containing same'
[patent_app_type] => utility
[patent_app_number] => 10/519208
[patent_app_country] => US
[patent_app_date] => 2003-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6555
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20060063801.pdf
[firstpage_image] =>[orig_patent_app_number] => 10519208
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/519208 | 3-(4-oxo-4H-chromen-2-yl)-(1H)-quinolin-4-one derivatives, method for preparing same and pharmaceutical compositions containing same | Jun 17, 2003 | Issued |
Array
(
[id] => 751000
[patent_doc_number] => 07022870
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-04
[patent_title] => 'N-bridged selective androgen receptor modulators and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/462837
[patent_app_country] => US
[patent_app_date] => 2003-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15974
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/022/07022870.pdf
[firstpage_image] =>[orig_patent_app_number] => 10462837
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/462837 | N-bridged selective androgen receptor modulators and methods of use thereof | Jun 16, 2003 | Issued |
Array
(
[id] => 1024929
[patent_doc_number] => 06884815
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-04-26
[patent_title] => 'High affinity small molecule C5a receptor modulators'
[patent_app_type] => utility
[patent_app_number] => 10/461311
[patent_app_country] => US
[patent_app_date] => 2003-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 58817
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/884/06884815.pdf
[firstpage_image] =>[orig_patent_app_number] => 10461311
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/461311 | High affinity small molecule C5a receptor modulators | Jun 11, 2003 | Issued |
Array
(
[id] => 785403
[patent_doc_number] => 06989392
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-01-24
[patent_title] => '2-Aminoquinolines as melanin concentrating hormone receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/460139
[patent_app_country] => US
[patent_app_date] => 2003-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36180
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/989/06989392.pdf
[firstpage_image] =>[orig_patent_app_number] => 10460139
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/460139 | 2-Aminoquinolines as melanin concentrating hormone receptor antagonists | Jun 11, 2003 | Issued |